{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:33:12Z","timestamp":1791516792092,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.medj.2026.101193","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:43:40Z","timestamp":1782917020000},"page":"101193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies"],"prefix":"10.1016","volume":"7","author":[{"given":"Lin","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3630-1604","authenticated-orcid":false,"given":"Ningyuan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoluo","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhekai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie B.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4709-3374","authenticated-orcid":false,"given":"Ning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2026.101193_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101193_bib2","doi-asserted-by":"crossref","first-page":"13049","DOI":"10.1073\/pnas.192460799","article-title":"Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect","volume":"99","author":"Bergo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2026.101193_bib3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1236764","article-title":"Biochemistry. A protease for the ages","volume":"339","author":"Michaelis","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.medj.2026.101193_bib4","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033670","article-title":"ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and\/or protein stability","volume":"11","author":"Spear","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.medj.2026.101193_bib5","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/s41390-023-02981-9","article-title":"Epidemiological characteristics of patients with Hutchinson-Gilford progeria syndrome and progeroid laminopathies in China","volume":"95","author":"Wang","year":"2024","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.medj.2026.101193_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40265-020-01464-z","article-title":"Lonafarnib: First Approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.medj.2026.101193_bib7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2018.3264","article-title":"Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome","volume":"319","author":"Gordon","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2026.101193_bib8","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2026.101193_bib9","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1172\/JCI85908","article-title":"Modulation of LMNA splicing as a strategy to treat prelamin A diseases","volume":"126","author":"Lee","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.medj.2026.101193_bib10","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddp184","article-title":"Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides","volume":"18","author":"Fong","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.medj.2026.101193_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002847","article-title":"Splicing-directed therapy in a new mouse model of human accelerated aging","volume":"3","author":"Osorio","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.medj.2026.101193_bib12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nm1204","article-title":"Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome","volume":"11","author":"Scaffidi","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2026.101193_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41591-021-01262-4","article-title":"Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson-Gilford progeria syndrome","volume":"27","author":"Puttaraju","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2026.101193_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41591-021-01274-0","article-title":"A targeted antisense therapeutic approach for Hutchinson-Gilford progeria syndrome","volume":"27","author":"Erdos","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2026.101193_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.add2187","article-title":"Robust deep learning-based protein sequence design using ProteinMPNN","volume":"378","author":"Dauparas","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.medj.2026.101193_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2026.101193_bib17","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","article-title":"Hutchinson-Gilford progeria syndrome: review of the phenotype","volume":"140A","author":"Hennekam","year":"2006","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.medj.2026.101193_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/acel.12621","article-title":"Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape","volume":"16","author":"Chen","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.medj.2026.101193_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81290","article-title":"Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification","volume":"11","author":"San Martin","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.medj.2026.101193_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/physiol.00036.2016","article-title":"Modeling Physiological Events in 2D vs. 3D Cell Culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.medj.2026.101193_bib21","doi-asserted-by":"crossref","first-page":"W135","DOI":"10.1093\/nar\/gkh449","article-title":"Sfold web server for statistical folding and rational design of nucleic acids","volume":"32","author":"Ding","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2026.101193_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1172\/JCI27125","article-title":"Prelamin A and lamin A appear to be dispensable in the nuclear lamina","volume":"116","author":"Fong","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.medj.2026.101193_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/embr.201338126","article-title":"Antagonistic functions of LMNA isoforms in energy expenditure and lifespan","volume":"15","author":"Lopez-Mejia","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.medj.2026.101193_bib24","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1073\/pnas.0600012103","article-title":"Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson\u2013Gilford progeria syndrome","volume":"103","author":"Varga","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2026.101193_bib25","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1073\/pnas.1906713117","article-title":"Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups","volume":"117","author":"Cubria","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2026.101193_bib26","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.yexcr.2007.03.028","article-title":"\u201cLaminopathies\u201d: A wide spectrum of human diseases","volume":"313","author":"Worman","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.medj.2026.101193_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/dmd.121.000418","article-title":"Adverse Drug Reactions and Toxicity of the Food and Drug Administration\u2013Approved Antisense Oligonucleotide Drugs","volume":"50","author":"Alhamadani","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.medj.2026.101193_bib28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nrg1906","article-title":"Human laminopathies: nuclei gone genetically awry","volume":"7","author":"Capell","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.medj.2026.101193_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-pathol-042220-034240","article-title":"Molecular Pathology of Laminopathies","volume":"17","author":"Shin","year":"2022","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.medj.2026.101193_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2023.06.002","article-title":"Hutchinson-Gilford Progeria Syndrome: Cellular Mechanisms and Therapeutic Perspectives","volume":"54","author":"Cisneros","year":"2023","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.medj.2026.101193_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tibs.2019.03.010","article-title":"Hutchinson\u2013Gilford Progeria Syndrome: Cardiovascular Pathologies and Potential Therapies","volume":"44","author":"Xu","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.medj.2026.101193_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41591-021-01274-0","article-title":"A targeted antisense therapeutic approach for Hutchinson\u2013Gilford progeria syndrome","volume":"27","author":"Erdos","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2026.101193_bib33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41591-021-01262-4","article-title":"Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson\u2013Gilford progeria syndrome","volume":"27","author":"Puttaraju","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2026.101193_bib34","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1093\/nar\/gkaa164","article-title":"Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice","volume":"48","author":"Chappell","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2026.101193_bib35","first-page":"6045","article-title":"Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates","volume":"47","author":"\u00d8stergaard","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2026.101193_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41587-019-0013-6","article-title":"Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides","volume":"37","author":"Merkle","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.medj.2026.101193_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101530","article-title":"A protocol for the generation of patient-specific iPSC lines from peripheral blood mononuclear cells","volume":"3","author":"Gao","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.medj.2026.101193_bib38","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","article-title":"Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling","volume":"109","author":"Lian","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2026.101193_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.medj.2026.101193_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/science.adu9375","article-title":"Gastruloids enable modeling of the earliest stages of human cardiac and hepatic vascularization","volume":"388","author":"Abilez","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.medj.2026.101193_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/jimaging8040095","article-title":"Spiky: An ImageJ Plugin for Data Analysis of Functional Cardiac and Cardiomyocyte Studies","volume":"8","author":"Pasqualin","year":"2022","journal-title":"J. Imaging"},{"key":"10.1016\/j.medj.2026.101193_bib42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41587-019-0106-2","article-title":"Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index","volume":"37","author":"Shen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.medj.2026.101193_bib43","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1093\/nar\/6.11.3543","article-title":"Hybridization of synthetic oligodeoxyribonucleotides to \u03a6X174 DNA: the effect of single base pair mismatch","volume":"6","author":"Wallace","year":"1979","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2026.101193_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-7188-6-26","article-title":"ViennaRNA Package 2.0","volume":"6","author":"Lorenz","year":"2011","journal-title":"Algorithms Mol. Biol."},{"key":"10.1016\/j.medj.2026.101193_bib45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2105-11-129","article-title":"RNAstructure: software for RNA secondary structure prediction and analysis","volume":"11","author":"Reuter","year":"2010","journal-title":"BMC Bioinf."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634026001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:49:45Z","timestamp":1789087785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634026001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666634026001960"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2026.101193","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2026.101193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101193"}}